Trials / Completed
CompletedNCT01286194
A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
A Multi-Center, Open-Label, All-Comers, Single Group Observational Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC )Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, open-label, all-comers OTC actual use study in pharmacy sites where the principal investigator will be a pharmacist.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rabeprazole sodium | Rabeprazole sodium 10 mg orally every day for 14 days |
Timeline
- Start date
- 2006-04-01
- Completion
- 2007-01-01
- First posted
- 2011-01-31
- Last updated
- 2011-01-31
Locations
33 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01286194. Inclusion in this directory is not an endorsement.